Main > ONCOLOGY (**) > BTC>Advanced or MET>Treat.> > TREAT.: > UK. A. PD-L1 MAb+CT (gemcitabine+ci

---

splatin

UK. A. PD-L1 MAb+CT (gemcitabine+ci's subsections
(*) EU CE Mark Date: 2022. 12.21
(*) USA Approval Date: 2022. 09.05
Company
PD-L1 MAb Generic Name:
RTM
RTM Web-Site
USA Patent Numbers:

UK. A. PD-L1 MAb+CT (gemcitabine+ci's products
This section has no products